Date Research Firm Action From To
May 24, 2011 MP Advisors Downgrade Outperform Market Perform
May 4, 2011 Brean Murray Downgrade Buy Hold
Feb 24, 2011 Wedbush Upgrade Neutral Outperform
Jan 28, 2011 Brean Murray Initiated Buy
Oct 7, 2010 Dawson James Initiated Buy
Sep 8, 2010 JMP Securities Downgrade Mkt Outperform Mkt Perform
May 26, 2010 Wedbush Upgrade Underperform Neutral
May 26, 2010 Mehta Partners Upgrade Market Perform Outperform
May 4, 2010 Mehta Partners Initiated Market Perform
Apr 12, 2010 JP Morgan Downgrade Overweight Neutral
May 24, 2011 MP Advisors Downgrade Outperform Market Perform
May 4, 2011 Brean Murray Downgrade Buy Hold
Feb 24, 2011 Wedbush Upgrade Neutral Outperform
Jan 28, 2011 Brean Murray Initiated Buy
Oct 7, 2010 Dawson James Initiated Buy
Sep 8, 2010 JMP Securities Downgrade Mkt Outperform Mkt Perform
May 26, 2010 Wedbush Upgrade Underperform Neutral
May 26, 2010 Mehta Partners Upgrade Market Perform Outperform
May 4, 2010 Mehta Partners Initiated Market Perform
Apr 12, 2010 JP Morgan Downgrade Overweight Neutral
Recent VRTX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:20:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:14:55 PM
- Halozyme signs licensing deal with Vertex for drug delivery technology • IH Market News • 04/07/2026 02:11:29 PM
- Vertex to Announce First Quarter 2026 Financial Results on May 4th • Business Wire • 04/06/2026 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:53:51 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 05:02:16 PM
- Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States • Business Wire • 04/01/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:03:47 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:04:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 08:11:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2026 03:38:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 01:44:31 PM
- Vertex Shares Jump After Positive Phase 3 Kidney Drug Results • IH Market News • 03/10/2026 03:45:15 PM
- Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy • Business Wire • 03/09/2026 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:05:56 PM
- Vertex to Participate in Upcoming March Investor Conferences • Business Wire • 03/05/2026 09:00:00 PM
- Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures • Business Wire • 03/05/2026 03:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:21:16 PM

